SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-15-001441
Filing Date
2015-03-09
Accepted
2015-03-09 17:00:45
Documents
7
Period of Report
2015-04-22
Effectiveness Date
2015-03-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A evokdef14a.htm DEF 14A 822779
2 GRAPHIC g201503091742400663501.jpg GRAPHIC 17621
3 GRAPHIC g201503091742409413502.jpg GRAPHIC 20720
4 GRAPHIC g201503091742415353503.jpg GRAPHIC 17621
5 GRAPHIC g201503091742573633504.jpg GRAPHIC 20720
6 GRAPHIC g201503091742577533505.jpg GRAPHIC 341495
7 GRAPHIC g201503091742579253506.jpg GRAPHIC 246373
  Complete submission text file 0001564590-15-001441.txt   1740450
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 15685902
SIC: 2834 Pharmaceutical Preparations